|
|
|
Issue Open Date
|
09-Feb-24
|
|
|
|
Issue Closing Date
|
13-Feb-24
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
1195
-
1258
|
|
|
|
Minimium Application No.
|
11
|
|
|
|
Issue Size (Shares)
|
7150100
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
Objective
|
|
1. Repayment/prepayment, in full or part, of certain borrowings availed of by our Company and our Subsidiaries2.Funding the long term working capital requirements3.Pursuing inorganic growth initiatives through acquisitions4.General corporate purposes
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
1960609
|
426756
|
0.217665021429566
|
|
Qualified Institutional Buyers
|
3808069
|
8686172
|
2.28099123203913
|
|
Retail Individual Investors
|
1307073
|
1743885
|
1.33419097479636
|
|
|
|
|
Business Description
Our Company was founded in 2018 by Prabhat Agrawal, our Promoter, Managing Director and Chief Executive Officer, and Prem Sethi, our Promoter, Whole-time Director and Chief Operating Officer, with the vision to create an organized, pan-India, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem. We add value to the healthcare product manufacturers that work with us by providing them reach and accessibility to pharmacies, hospitals and clinics through our integrated and technology driven, pan-India healthcare products distribution platform. As of March 31, 2023, our 73 warehouses located across the country, last-mile delivery infrastructure and relationships with pharmacies, hospitals and clinics enables healthcare product manufacturers to make their products available to a wide range of customers. Similarly, the pharmacies, hospitals and clinics that we service get access to a wide range of healthcare products through our distribution infrastructure and our healthcare product manufacturer relationships. During the Financial Years 2021, 2022 and 2023, we catered to over 39,500, 64,200 and 81,400 retail customers, respectively, and over 1,600, 2,500 and 3,400 hospital customers, respectively. Further, as of March 31, 2023, we have supply relationships with over 1,900 healthcare product manufacturers that gives us access to over 64,500 product stock-keeping units (“SKUs”).
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
12668193
|
|
|
|
Offered to Public
|
7150100
|
|
|
|
Promoter's Holding (Pre-Issue)
|
78.85
|
|
|
|
Promoter's Holding (Post-Issue)
|
52.44
|
|
|
|
|
|
|
|
|
|
|
Address |
Plot No. I-35
Building - B
Industrial Area Phase - I
13/7 Mathura Road
Faridabad,
Haryana,
121003
Phone :
Email : jayant.prakash@enterohealthcare.com
Website : www.enterohealthcare.com
|
|
|
Registrar |
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
|
|
|
Listed at |
|
BSE, NSE
|
|
|
Lead Manager |
Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.)
ICICI Securities Ltd
Jefferies India Pvt Ltd.
JM Financial Ltd.
SBI Capital Markets Ltd
|
|
|
Promoters |
Orbimed Asia Iii Mauritius Ltd.
Prabhat Agrawal
Prem Sethi
|
|
